Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box–Behnken experimental design

Drug Development and Industrial Pharmacy

Volumn 42, Issue 5, 2016, Pages 747-757

  Gajra, Balaram ^a   Patel, Ravi R ^a,b   Dalwadi, Chintan ^a  

^a CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Allergic rhinitis; Box Behnken experimental design; Chitosan nanoparticles; Permeability enhancement; Sodium cromoglicate

Indexed keywords

CATION; CHITOSAN NANOPARTICLE; CROMOGLYCATE DISODIUM; NANOPARTICLE; STABILIZING AGENT; CHITOSAN; DELAYED RELEASE FORMULATION; DRUG CARRIER; EXCIPIENT; POLYMER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; EX VIVO STUDY; EXPERIMENTAL DESIGN; GELATION; IN VITRO STUDY; MAST CELL; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; RAT; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY; METHODOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; CATIONS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; MAST CELLS; NANOPARTICLES; PARTICLE SIZE; POLYMERS; RATS, WISTAR; RESEARCH DESIGN;

EID: 84968615924     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2015.1093496     Document Type: Article

References (42)

1. Sukumaran TU. Allergic rhinitis and co-morbidities training module. Indian Pediatr 2011;48:511–13.
2. Budavari S. The merck index: an encyclopedia of chemicals, drugs, and biologicals (Merck Index). Rahway (NJ): MERCK & CO., Inc.; 1989.
3. Sweetman S. Martindale the complete drug reference. London: Pharmaceutical Press; 2005.
4. Ding X, Rath P, Angelo R, et al. Oral absorption enhancement of cromolyn sodium through noncovalent complexation. Pharm Res 2004;21:2196–206.
5. Gupta R. Nanoparticle technology for drug delivery. New York, USA: Taylor & Francis Group; 2006.
6. Kaur SP, Rao R, Hussain A, et al. Preparation and characterization of rivastigmine loaded chitosan nanoparticles. J Pharm Sci Res 2011;3:1227–32.
7. Saha P, Goyal A, Rath G. Formulation and evaluation of chitosanbased ampicillin trihydrate nanoparticles. Trop J Pharm Res 2010;9: 483–8.
8. Patel RR, Kumar N, Khan G, et al. Investigation of critical variables of core-shell polymeric lipid hybrid nanoparticles by using plackettburman screening design. Adv Sci Lett 2014;20:923–32.
9. Box GEP, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455–76.
10. Calvo P, Remunan-Lopez C, Vila-Jato JL, et al. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 1997; 14:1431–6.
11. Gajra B, Dalwadi C, Patel RR. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (lipomer) using Box–Behnken design. Daru 2015;23:3
12. Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box–Behnken design. AAPS Pharm Sci Tech 2007;8:E1–7.
13. Chaubey P, Patel RR, Mishra B. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opin Drug Deliv 2014;11:1163–81.
14. Guhagarkar S, Gaikwad R, Samad A, et al. Polyethylene sebacatedoxorubicin nanoparticles for hepatic targeting. Int J Pharm 2010; 401:113–22.
15. Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 2009;37:508–13.
16. Lin YS, Haynes CL. Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles. Chem Mater 2009;21:3979–86.
17. Chaurasia S, Kumar N, Patel RR, et al. Optimization of parameters for the fabrication of curcumin loaded polymeric nanoparticles using Taguchi robust design. Adv Sci Lett 2014;20:1028–38.
18. Barthe L, Woodley JF, Kenworthy S, et al. An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metab Pharmacokinet 1998;23:313–23.
19. Woitiski CB, Sarmento B, Carvalho RA, et al. Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm 2011;412:123–31.
20. Katas H, Wen CM. Preparation and characterization of highly loaded fluorescent chitosan nanoparticles. ISRN Pharm 2011;1–5.
21. Wilson B, Samanta MK, Santhi K, et al. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine 2010;6:144–52.
22. Meng J, Sturgis T, Youan B. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci 2011;44:57–67.
23. Avadi MR, Sadeghi AM, Mohammadpour N, et al. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine 2010;6:58–63.
24. Thagele R, Mishra A, Pathak A. Formulation and characterization of clarithromycin based nanoparticulate drug delivery system. Int J Pharm Life Sci 2011;2:510–15.
25. Ko JA, Park HJ, Hwang SJ, et al. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002;249:165–74.
26. Hans M, Lowman A. Biodegradable nanoparticles for drug delivery and targeting. Cur Opin Sol Stat Mater Sci 2002;6:319–27.
27. Muller R, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3–19.
28. Wang J, Tauchi Y, Deguchi Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv 2000;7:237–43.
29. Alani AWG, Robinson JR. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative. Pharm Res 2008;25:48–54.
30. Rao N, Kulkarni U, Deshmukh A, et al. Preparation and characterization of ionotropic cross-linked chitosan microparticles for controlled release of aceclofenac. Int J Pharm Sci Drug Res 2010; 2:107–11.
31. Liao S, Hung C. A kinetic study of thermal degradation of chitosan/ polycaprolactam blends. Macromol Res 2004;12:466–73.
32. Nolan LM, Li J, Tajber L, et al. Particle engineering of materials for oral inhalation by dry powder inhalers. II-sodium cromoglicate. Int J Pharm 2011;405:36–46.
33. Kumar N, Chaurasia S, Patel RR, et al. Development and optimization of atorvastatin calcium loaded oral biodegradable polymeric nanoparticles using central composite design. Adv Sci Lett 2014;20:984–93.
34. Yoksan R, Jirawutthiwongchai J, Arpo K. Encapsulation of ascorbyl palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic gelation processes. Colloids Surf B Biointerfaces 2010;76: 292–97.
35. Zhao A, Wang T, Yao M, et al. Effects of chitosan-TPP nanoparticles on hepatic tissue after severe bleeding. J Med Coll PLA 2011;26:283–92.
36. Fan W, Yan W, Xu Z, et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces 2012;90:21–27.
37. Rejinold NS, Muthunarayanan M, Divyarani VV, et al. Curcuminloaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J Colloid Interface Sci 2011;360:39–51.
38. Chaurasia S, Patel RR, Chaubey P, et al. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin. Carbohydr Polym 2015;130:9–17.
39. Schipper N, Olsson S, Hoogstraate J, et al. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 1997;14:923–9.
40. Huang M, Ma Z, Khor E, et al. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 2002;19:1488–94.
41. Sarmento B, Ribeiro A, Veiga F, et al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007;24:2198–206.
42. Morris G, Castile J, Smith A, et al. The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP) – chitosan nanoparticles. Carbohyd Polym 2011;84:1430–4.